Correction: Normalization of tumor vasculature by imiquimod: proposal for a new anticancer therapeutic indication for a TLR7 agonist
Saved in:
| Main Authors: | Magdalena Jarosz-Biej, Justyna Czapla, Joanna Ciepła, Ryszard Smolarczyk, Alina Drzyzga, Dorota Sprus-Lipka, Ewelina Pilny, Sybilla Matuszczak, Tomasz Cichoń |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-05-01
|
| Series: | Cancer Immunology, Immunotherapy |
| Online Access: | https://doi.org/10.1007/s00262-025-04062-8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Normalization of tumor vasculature by imiquimod: proposal for a new anticancer therapeutic indication for a TLR7 agonist
by: Jarosz-Biej Magdalena, et al.
Published: (2025-02-01) -
Lignin-chitosan-based biocomposite film for the localized delivery of TLR7 agonist imiquimod
by: Aashna Jassal, et al.
Published: (2024-11-01) -
A Chemically Defined TLR3 Agonist with Anticancer Activity
by: Julie Le Naour, et al.
Published: (2023-12-01) -
NOD2 Agonist Promotes the Production of Inflammatory Cytokines in VSMC in Synergy with TLR2 and TLR4 Agonists
by: Jinghua Sun, et al.
Published: (2012-01-01) -
De novo design of protein minibinder agonists of TLR3
by: Chloe S. Adams, et al.
Published: (2025-01-01)